Graphene Manufacturing Group Ltd. (TSX-V: GMG) (“GMG” or the
“Company”) is pleased to announce that it is commencing a marketed
offering (the "Offering") of units (the "Units") of the Company.
Each Unit will consist of one ordinary share of the Company (a
"Common Share") and one-half of one ordinary share purchase warrant
(each whole ordinary share purchase warrant, a "Warrant").
The Units will be offered under the amended and
restated base shelf prospectus of the Company receipted on August
3, 2023 (the "Base Shelf Prospectus"), as supplemented by a shelf
prospectus supplement (the "Supplement") to be prepared and filed
in each of the provinces of British Columbia, Alberta, Saskatchewan
and Ontario (collectively, the "Jurisdictions") and by way of a
private placement in the United States, and in those jurisdictions
outside of Canada and the United States which are agreed to by the
Company and the Underwriters (as defined below), where the Units
can be issued on a private placement basis, exempt from any
prospectus, registration or other similar requirements.
The total size of the Offering as well as
certain other terms of the Units and the Warrants (including the
term and the exercise price of each Warrant) will be determined in
the context of the market at the time of pricing. There can be no
assurance as to whether or when the Offering may be completed, or
as to the actual size or terms of the Offering. The closing of the
Offering remains subject to market and other customary conditions,
including but not limited to, the receipt of all necessary
approvals, including the approval of the TSX Venture Exchange (the
“TSXV”) and the applicable securities regulatory authorities.
Raymond James is acting as sole bookrunner for
the Offering on behalf of a syndicate of underwriters to be named
(collectively, the "Underwriters").
The Company intends to grant the Underwriters an
option (the "Over-Allotment Option") to cover over-allotments and
for market stabilization purposes, exercisable at any time up to 30
days subsequent to the closing of the Offering, to purchase up to
an additional 15.0% of the Units, pursuant to the Offering on the
same terms and conditions of the Offering. The Over-Allotment
Option will be exercisable to acquire Units, Common Shares and/or
Warrants (or any combination thereof) at the discretion of the
Underwriters.
The Company will pay the Underwriters a cash
commission equal to 6.0% of the gross proceeds of the Offering,
including proceeds received from the exercise of the Over-Allotment
Option. In addition, the Company will issue the Underwriters
compensation warrants to purchase up to 6.0% of the aggregate
number of Units issued pursuant to the Offering, including any
Units issued upon exercise of the Over-Allotment Option (the
“Compensation Warrants”). Each Compensation
Warrant shall entitle the Underwriters to purchase one Unit at the
Offering Price at any time on or before the date which is 36 months
following closing of the Offering.
The net proceeds of the Offering are expected to
be used primarily to strengthen the Company's financial position
and provide liquidity to finance ongoing operations, including, in
particular, the Company’s expenses incurred, and expected to be
incurred, in connection with the Company’s research and
development objectives, and for working capital and general
corporate purposes.
Copies of the Supplement and the Base Shelf
Prospectus can be obtained on SEDAR+ at www.sedarplus.ca and from
Raymond James Ltd, 5300 – 40 King Street West, Scotia Plaza, P.O.
Box 415, Toronto, Ontario, M5H 3Y2, attention:
ECM-syndication@raymondjames.ca. The Supplement and the Base Shelf
Prospectus contain important detailed information about the Company
and the proposed Offering. Prospective investors should read the
Supplement and the Base Shelf Prospectus and the other documents
the Company has filed on SEDAR+ before making an investment
decision.
This press release shall not constitute an offer
to sell or the solicitation of an offer to buy nor shall there be
any sale of the securities in any state in which such offer,
solicitation or sale would be unlawful. The securities being
offered have not been, nor will they be, registered under the
United States Securities Act of 1933, as amended, and may not be
offered or sold in the United States absent registration or an
applicable exemption from the registration requirements of the
United States Securities Act of 1933, as amended, and applicable
state securities laws.
About GMG
GMG is a disruptive Australian-based clean-tech
company listed on the TSXV (TSXV: GMG) that produces graphene and
hydrogen by cracking methane (natural gas) instead of mining
graphite. By using the company’s proprietary process, GMG can
produce high quality, low cost, scalable, ‘tuneable’ and no/low
contaminant graphene – enabling demonstrated cost and environmental
improvements in a number of world-scale planet-friendly/clean-tech
applications. Using this low input cost source of graphene, the
Company is developing value-added products that target the massive
energy efficiency and energy storage markets. The Company is
pursuing additional opportunities for GMG Graphene, including
developing next-generation batteries, collaborating with
world-leading universities in Australia, and investigating the
opportunity to enhance the performance of lubricant oil and
performance-enhanced HVAC-R coating system.
For further information please contact:
- Craig Nicol, Chief Executive Officer and Managing Director of
the Company at craig.nicol@graphenemg.com, +61 415 445 223
- Leo Karabelas at Focus Communications Investor Relations,
leo@fcir.ca, +1-647-689-6041
www.graphenemg.com
Neither the TSX Venture Exchange nor its
Regulation Services Provider (as that term is defined in the
policies of the TSX Venture Exchange) accept responsibility for the
adequacy or accuracy of this news release.
Cautionary Note Regarding
Forward-Looking Statements
This news release includes certain statements
and information that may constitute forward-looking information
within the meaning of applicable Canadian securities laws.
Forward-looking statements relate to future events or future
performance and reflect the expectations or beliefs of management
of the Company regarding future events. Generally, forward-looking
statements and information can be identified by the use of
forward-looking terminology such as “intends”, “expects” or
“anticipates”, or variations of such words and phrases or
statements that certain actions, events or results “may”, “could”,
“should”, “would” or will “potentially” or “likely” occur. This
information and these statements, referred to herein as
“forward‐looking statements”, are not historical facts, are made as
of the date of this news release and include without limitation,
the Company's ability to complete the Offering on the terms
announced or at all, the use of the net proceeds of the Offering,
and the receipt of all necessary approvals, including the approval
of the TSXV, and the Company’s objectives, goals or future
plans.
Such forward-looking statements are based on a
number of assumptions of management, including, without limitation,
assumptions regarding the ability of the Company to achieve the
expected results of its products in research and development, that
the Company will be able to research, develop and produce certain
products as anticipated, that the Company will be able to engage
third parties and develop relationships to assist in the
development, distribution and sale of its products, and assumptions
regarding the completion of the Offering and the timing thereof.
Additionally, forward-looking information involve a variety of
known and unknown risks, uncertainties and other factors which may
cause the actual plans, intentions, activities, results,
performance or achievements of GMG to be materially different from
any future plans, intentions, activities, results, performance or
achievements expressed or implied by such forward-looking
statements. Such risks include, without limitation: the Offering
will not be completed on the timetable anticipated or at all, the
use of proceeds from the Offering will differ from management’s
current expectations, the engagement of the Underwriters in
connection with the Offering will not continue as expected, the
Company will not obtain all necessary approvals, including the
approval of the TSXV and applicable securities regulatory
authorities, the Company will not be able to use its products as
expected or the performance, safety profile and production and
maintenance requirements of the Company’s products will not be
consistent with management’s expectations, the impact of the
Company’s products will not be consistent with management’s
expectations, the Company will not be able to research, develop and
produce certain products, the Company will not be successful in
engaging third parties and developing relationships to assist in
the development, distribution and sale its products, public health
crises such as the COVID-19 pandemic may adversely impact the
Company’s business and the ability of the Company to develop its
products, risks relating to the extent and duration of the conflict
in Eastern Europe and its impact on global markets, the volatility
of global capital markets, political instability, the failure of
the Company to attract and retain skilled personnel, unexpected
development and production challenges, unanticipated costs and the
risk factors set out under the heading “Risk Factors” in the
Company’s annual information form dated October 18, 2022 available
for review on the Company’s profile at www.sedar.com.
Although management of the Company has attempted
to identify important factors that could cause actual results to
differ materially from those contained in forward-looking
statements or forward-looking information, there may be other
factors that cause results not to be as anticipated, estimated or
intended. There can be no assurance that such statements will prove
to be accurate, as actual results and future events could differ
materially from those anticipated in such statements. Accordingly,
readers should not place undue reliance on forward-looking
statements and forward-looking information. Readers are cautioned
that reliance on such information may not be appropriate for other
purposes. The Company does not undertake to update any
forward-looking statement, forward-looking information or financial
out-look that are incorporated by reference herein, except in
accordance with applicable securities laws. We seek safe
harbor.
Graphene Manufacturing (TSXV:GMG)
Historical Stock Chart
Von Nov 2024 bis Dez 2024
Graphene Manufacturing (TSXV:GMG)
Historical Stock Chart
Von Dez 2023 bis Dez 2024